Chunguang Li

发表

Clinical pharmacogenetics and potential application in personalized medicine.

Wei Duan, Shu-Feng Zhou, Charlie Changli Xue, 2008, Current drug metabolism.

Regulation of human pregnane X receptor and its target gene cytochrome P450 3A4 by Chinese herbal compounds and a molecular docking study

M. Huang, W. Duan, Shufeng Zhou, 2011, Xenobiotica; the fate of foreign compounds in biological systems.

Computational and in vitro studies on the inhibitory effects of herbal compounds on human cytochrome P450 1A2

Shufeng Zhou, K. Sneed, Zhi-Wei Zhou, 2012, Xenobiotica; the fate of foreign compounds in biological systems.

Role of P-glycoprotein in Limiting the Brain Penetration of Glabridin, An Active Isoflavan from the Root of Glycyrrhiza glabra

E. Chan, W. Duan, Shufeng Zhou, 2007, Pharmaceutical Research.

Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development.

W. Duan, Shufeng Zhou, C. Xue, 2008, Current medicinal chemistry.

Aptamers as Theranostic Agents: Modifications, Serum Stability and Functionalisation

Tao Wang, Yimin Zhu, Wei Duan, 2013, Sensors.

In vitro and in vivo neuroprotective effect and mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra (licorice).

Shufeng Zhou, C. Xue, Zhi-Wei Zhou, 2008, Life sciences.

Prediction of deleterious functional effects of non-synonymous single nucleotide polymorphisms in human nuclear receptor genes using a bioinformatics approach.

Shufeng Zhou, Chunguang Li, Ya-He Liu, 2009, Drug metabolism letters.

Tanshinone IIB, a primary active constituent from Salvia miltiorrhza, exhibits neuro-protective activity in experimentally stroked rats

Shufeng Zhou, E. Chan, W. Duan, 2007, Neuroscience Letters.

Mechanism of reversal of high glucose-induced endothelial nitric oxide synthase uncoupling by tanshinone IIA in human endothelial cell line EA.hy926.

Shufeng Zhou, Zhi-Wei Zhou, Chunguang Li, 2012, European journal of pharmacology.

Identification of drugs that interact with herbs in drug development.

Shufeng Zhou, C. Xue, A. Herington, 2007, Drug discovery today.

Interaction of Herbal Compounds with Biological Targets: A Case Study with Berberine

Shufeng Zhou, Zhi-Wei Zhou, Y. Di, 2012, TheScientificWorldJournal.

Tanshinone IIB, a primary active constituent from Salvia miltiorrhiza, exerts neuroprotective effect via inhibition of neuronal apoptosis in vitro

Shufeng Zhou, C. Xue, Zhi-Wei Zhou, 2008, Phytotherapy research : PTR.

Determination of Cryptotanshinone, a Major Active Component in Salvia miltiorrhiza, in Caco-2 Monolayers by HPLC with UV Detection

Shufeng Zhou, C. Xue, Zhi-Wei Zhou, 2007 .

Pharmacophore, QSAR, and binding mode studies of substrates of human cytochrome P450 2D6 (CYP2D6) using molecular docking and virtual mutations and an application to chinese herbal medicine screening.

Shufeng Zhou, Hai-bin Luo, H. Chew, 2012, Current pharmaceutical biotechnology.

Clinically Important Drug Interactions Potentially Involving Mechanism-based Inhibition of Cytochrome P450 3A4 and the Role of Therapeutic Drug Monitoring

Shufeng Zhou, C. Xue, Guangji Wang, 2007, Therapeutic drug monitoring.

Fire and Ice: The Great Debate on the Relative Value of Heat and Ice in Musculoskeletal Therapy - a Narrative Review

Shufeng Zhou, C. Xue, Zhi-Wei Zhou, 2007 .

Phenotype prediction of non-synonymous single-nucleotide polymorphisms in human ATP-binding cassette transporter genes.

Shufeng Zhou, Chunguang Li, Ya-He Liu, 2011, Basic & clinical pharmacology & toxicology.

Clinical drugs that interact with St. John's wort and implication in drug development.

Shufeng Zhou, C. Xue, Y. Di, 2008, Current pharmaceutical design.